WhaleCreep

Whitefort Capital Management, LP 13F holdings, Q3 2025

Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →

Whitefort Capital Management, LP disclosed 16 US equity positions worth $302.1m in its Q3 2025 13F filing. The largest position was ABUS at 20.1% of the reported book, followed by ROIV and GNW. Against the Q2 2025 filing, it opened 2 new positions, added to 5 and reduced 3 among the top 16 holdings.

← Q2 2025 · Q4 2025 →

What did Whitefort Capital Management, LP own in Q3 2025? Top 16 positions

#StockSectorWeightValueSharesΔ sharesvs Q2 2025
1 ABUS ARBUTUS BIOPHARMA CORP Healthcare 20.1%$60.6m13,343,228 0% held
2 ROIV ROIVANT SCIENCES LTD Healthcare 17.7%$53.4m3,532,000 -9% reduced
3 GNW GENWORTH FINL INC Financial Services 10.9%$32.9m3,701,960 15% added
4 JOYY JOYY INC Communication Services 7.9%$23.7m404,944 -56% reduced
5 OABI OMNIAB INC 7.5%$22.8m14,223,658 39% added
6 CDZI CADIZ INC 6.2%$18.8m3,986,822 0% held
7 BALY BALLYS CORPORATION 4.9%$14.9m1,343,243 – new
8 TDAY GANNETT CO INC Communication Services 4.9%$14.8m3,585,406 34% added
9 OPKO HEALTH INC 4.8%$14.4m9,350,000 0% held
10 LQDA LIQUIDIA CORPORATION Healthcare 4.6%$13.8m607,409 -54% reduced
11 SGRY SURGERY PARTNERS INC Healthcare 2.7%$8.0m371,000 0% held
12 IWM ISHARES TR 2.6%$8.0m33,000 – new
13 OPK OPKO HEALTH INC Healthcare 2.5%$7.6m4,900,000 176% added
14 KG KESTREL GROUP LTD 1.5%$4.4m160,916 57% added
15 VATE INNOVATE CORP 1.2%$3.6m743,000 0% held
16 NEXTNAV INC 0.1%$255.7k47,264 0% held

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.